US 11090396
Compounds and methods for the detection of TRPV-6 cancers and drug delivery
granted A61KA61K31/337A61K33/24
Quick answer
US patent 11090396 (Compounds and methods for the detection of TRPV-6 cancers and drug delivery) held by Soricimed Biopharma Inc. expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Soricimed Biopharma Inc.
- Grant date
- Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/337, A61K33/24, A61K33/242, A61K39/0005